Viewing Study NCT05817903


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2025-12-29 @ 11:48 PM
Study NCT ID: NCT05817903
Status: RECRUITING
Last Update Posted: 2023-05-08
First Post: 2023-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients
Sponsor: Consorzio Oncotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module